Contract Manufacturing, General

Mar 02, 2011
BioPharm International
The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.
Mar 01, 2010
BioPharm International
Collaborations between Western and Indian companies may provide the best path for offshoring successfully and for developing India's readiness.
Dec 01, 2009
BioPharm International
A new analysis highlights growth opportunities and challenges for contract development and manufacturing organizations.
Nov 01, 2009
BioPharm International
An enterprise-wide quality management initiative is required to maintain supplier quality without sacrificing bottom-line objectives.
Oct 01, 2009
BioPharm International
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
Sep 01, 2009
BioPharm International
To select the right partner for media design and optimization services, several key factors must be considered.
Jan 01, 2009
BioPharm International
How to ensure smooth technology transfers.
Nov 01, 2008
BioPharm International
If Indian biologics manufacturers can establish a track record for recombinant products, enhance quality image, maintain cost competitiveness, and demonstrate technology transfer and regulatory knowhow, they are likely to be in the middle of the next boom in biologics manufacturing.
Nov 01, 2008
BioPharm International
There could be a serious glut of commercial scale mammalian cell culture capacity over the next five years. Then again, there could be a significant shortage. It all depends on how things develop in expression technology, the new product pipeline, and corporate strategies.
May 01, 2008
BioPharm International
The current overcapacity situation in the bio/pharmaceutical industry is a reminder that CMOs need to come up with business models and value propositions that are based on more than just selling capacity.
native1_300x100
lorem ipsum